Human medicines
Fragmin
The marketing authorization holder informed its supplied customers in a letter dated February 3, 2011, that empty or almost empty prefilled syringes…
Pegasys
The marketing authorization holder has informed its supplied customers in a letter dated January 25, 2011, that cracks have been detected in the cone…
Ebixa
The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed the wholesalers supplied that all batches with…
Dianeal
Two batches of the product Dianeal have been identified that may contain endotoxins. Therefore, the marketing authorization holder has decided to…
Nutrineal
The marketing authorization holder has received increased adverse reactions (aseptic peritonitis) to the above batch. Therefore, Baxter Healthcare has…
Glucobene tablets
The marketing authorization holder informed its supplied customers in a fax transmission on December 20, 2010, that due to complaints on the German…
Myocholine-Glenwood Tablets
The distribution partner Croma-Pharma has informed the supplied customers by letter dated December 9, 2010, that the above mentioned batches have to…
Migradon
The marketing authorization holder informed its supplied customers in a letter dated December 13, 2010, that the affected batch exhibited significant…
PegIntron
The marketing authorization holder informed its supplied customers by letters dated October 29 and November 25, 2010, that the sterility of the…
Velcade
The marketing authorization holder has informed its supplied customers by letter dated 18.11.2010 that due to 5 complaints about visible particles…
